As an oncogene, PRMT5 serves critical functions in several cellular responses, including the development, progression, and aggressiveness of cancer, and has been studied in multiple tumour types, including leukaemia, lymphoma, lung cancer, liver cancer, colorectal cancer and breast cancer39–43. The gene discussed is PRMT5; the disease is lung cancer.